CD4 and glioblastoma: Indeed, for example, the analysis of immune composition within the tumor post-vaccination, subsequent to relapse (of glioblastoma) showed an increased infiltration of CD4 and CD8 T cells comprising neoepitope-specific T cells, for the two patients who had previously responded to the vaccine, as compared to tumor at baseline (178).